Comparative Effectiveness of Gastric Bypass and Vertical Sleeve Gastrectomy for Hypertension Remission and Relapse: The ENGAGE CVD Study. Issue 4 (October 2021)

• Record Type: Journal Article
• Authors: Reynolds, Kristi; Barton, Lee J.; Basu, Anirban; Fischer, Heidi; Arterburn, David E.; Barthold, Douglas; Courcoulas, Anita; Crawford, Cecelia L.; Kim, Benjamin B.; Fedorka, Peter N.; Mun, Edward C.; Murali, Sameer B.; Zane, Robert E.; Coleman, Karen J.
• Is Part Of: Hypertension. Volume 78:Issue 4(2021)
• Publication Date: 2021-10
• Subjects: Bariatric surgery -- blood pressure -- comparative study -- gastrectomy -- gastric bypass; Hypertension -- Periodicals; Hypertension -- Treatment -- Periodicals; 616.132005
• DOI: 10.1161/HYPERTENSIONAHA.120.16934
• Languages: English
• ISSNs: 0194-911X

Abstract

Abstract : Weight loss is an effective strategy for the management of hypertension, and bariatric surgery is the most effective weight loss and maintenance strategy for obesity. The importance of bariatric surgery in the long-term management of hypertension and which operation is most effective is less clear. We compared the effectiveness of vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB) for remission and relapse of hypertension after surgery in the ENGAGE CVD cohort study (Effectiveness of Gastric Bypass Versus Gastric Sleeve for Cardiovascular Disease). Operations were done by 23 surgeons across 9 surgical practices. Hypertension remission and relapse were assessed in each year of follow-up beginning 30 days and up to 5 years postsurgery. We used a local instrumental variable approach to account for selection bias in the choice of VSG or RYGB. The study population included 4964 patients with hypertension at the time of surgery (n=3186 VSG and n=1778 RYGB). At 1 year, 27% of patients with RYGB and 28% of patients with VSG achieved remission. After 5 years, without accounting for relapse, 42% of RYGB and 43% of VSG patients had experienced hypertension remission. After accounting for relapse, only 17% of RYGB and 18% of VSG patients remained in remission 5 years after surgery. There were no statistically significant differences between VSG and RYGB for hypertension remission, relapse, or mean systolic and diastolic blood pressure at any time during follow-up. Abstract : Supplemental Digital Content is available in the text.